Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.
about
The impact of obesity towards prostate diseasesProstate cancer: intriguing data on inflammation and prostate cancer.Clinical correlates of enlarged prostate size in subjects with sexual dysfunctionAssociation between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.A histopathological study of prostate lesions in Lagos, Nigeria: A private practice experience.NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients.Prenatal and pubertal testosterone exposure imprint permanent modifications in the prostate that predispose to the development of lesions in old Mongolian gerbils.Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.Injectable testosterone undecanoate for the treatment of hypogonadism.Transurethral resection of the prostate achieves favorable outcomes in stroke patients with symptomatic benign prostate hyperplasia.Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.Lower urinary tract symptoms and metabolic disorders: ICI-RS 2014.Aging and sexual health: getting to the problem.Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies?Endocrine control of benign prostatic hyperplasia.Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.Use of thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology.Meta-analysis of metabolic syndrome and prostate cancer.Testosterone Replacement Therapy: Long-Term Safety and Efficacy.Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry.Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplas5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia.Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study.Benign prostatic enlargement is not associated with diabetes: a population-based study.Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.Positive Response to Thermobalancing Therapy Enabled by Therapeutic Device in Men with Non-Malignant Prostate Diseases: BPH and Chronic Prostatitis.Musulju improves benign prostatic hyperplasia by regulating inflammatory and apoptotic proteins.How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases.Obesity-initiated metabolic syndrome promotes urinary voiding dysfunction in a mouse modelEndogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients.Relationship between erectile dysfunction and the neutrophil to lymphocyte and platelet to lymphocyte ratios.Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base.Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients
P2860
Q26750847-F1369F85-B283-4183-A515-E5BCA6D1043EQ30834157-59F57C58-8CA3-41E6-86D4-2DF9A325056BQ34433316-98A5B07A-29CB-4D54-8EAE-47043D24954FQ36080363-6B761E19-2DFB-4F2E-9EB5-487D77C3EB25Q36423713-7B895AAA-97CB-4DA6-94CD-2D0B505F5AA0Q37018606-865365F0-509A-40BA-9875-7C4D9F2DB8ADQ37156314-778B0D4D-1AFF-43C7-A883-BCD6F73994CEQ37644650-8FC8F817-A5EC-49FC-AD48-2F1AA62274F9Q37678957-28655E64-2A7B-4534-A52F-0B0223345355Q38235669-49ADA61B-E402-4AF7-858B-F458104BE02BQ38649444-B8E7B849-FC21-4154-B5AE-127D26ED0936Q38692706-F5B34A0C-9B7E-4230-A3F3-F3068F0B84B6Q38731387-A0E20343-7FC1-4384-BB26-B853D397146FQ38738470-7636A1DE-A927-447D-B346-67F763AE4000Q38786798-D0F72D29-9A87-407B-A6F5-60CBE9DCDC78Q38811041-7E735F0B-BEB3-4A79-A5AC-6609860A4AB5Q38814349-B3321F61-7481-4AC6-B9AE-49ED887F9499Q38939314-3A76DA79-E14D-4F95-912C-4D176390AD7DQ39104684-A9DC5719-9DD6-4F97-A5F1-7A47198FEF25Q39145052-5B12B78A-61AF-4371-B3A9-8775B0C8A323Q39302080-806CDE6B-A28A-4777-9894-6451D92AF543Q39870160-9370136B-1465-4246-9185-069921C9CD66Q40615541-2C69D095-1A40-4CBF-A3CF-69B342741B29Q41207124-ADD1D828-6FB5-478B-8205-CE453E72385BQ41337202-F0A082D3-0889-4B17-885B-1C56144BA9D5Q41542467-EC9377B4-7A51-42CA-9E18-B533BDDB96CDQ41568393-3D9CC400-8036-42FA-A164-7B71887B3DEEQ42023192-B02BEC95-C4E5-4490-A1BD-6E9F6606B9EDQ42371431-75643991-8E72-4E7E-9A57-607DC0067794Q42375555-0302E134-551C-4195-839E-9DD16F2B696AQ42418839-393360F6-993E-4BE0-9FAB-6386F61DBF23Q46140496-090A618D-DD0F-430D-BB56-43CF37133A14Q47202604-7382537C-E52E-473D-94F6-F1E17F33B7E0Q47614558-E0F4A64E-A5BB-4B5F-8211-1ADCE8C1C9ACQ50054306-4E9F208F-0FFF-4E74-8E43-13B43531A327Q53212746-AB934112-2D05-42E5-864F-C1C28742D628Q57492460-202B8D3F-B7A8-4EC5-9443-AF3CC46AB4D2
P2860
Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Benign prostatic hyperplasia: ...... tion with sexual dysfunctions.
@en
Benign prostatic hyperplasia: ...... tion with sexual dysfunctions.
@nl
type
label
Benign prostatic hyperplasia: ...... tion with sexual dysfunctions.
@en
Benign prostatic hyperplasia: ...... tion with sexual dysfunctions.
@nl
prefLabel
Benign prostatic hyperplasia: ...... tion with sexual dysfunctions.
@en
Benign prostatic hyperplasia: ...... tion with sexual dysfunctions.
@nl
P2860
P50
P356
P1476
Benign prostatic hyperplasia: ...... ation with sexual dysfunctions
@en
P2093
Giovanni Corona
Sarah Cipriani
P2860
P304
P356
10.1155/2014/329456
P577
2014-02-13T00:00:00Z